Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pabinger

Showing results (111-120 of 211) with videos related to

Pageof 22
Sort By:
Journal of Thrombosis and Haemostasis : JTH|November 11, 2014
Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS)I Pabinger, C Ay, D Dunkler, et al.
Human Mutation|January 1, 1994
(ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutationsR J Olds, D A Lane, V Chowdhury, et al.
British Journal of Haematology|February 13, 2001
Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)M Jansen, S Schmaldienst, S Banyai, et al.
Thrombosis Research|October 23, 1997
Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathwayK Ruzicka, S Kapiotis, P Quehenberger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 4, 2017
Haemophilia patients' unmet needs and their expectations of the new extended half-life factor concentratesS von Mackensen, W Kalnins, J Krucker, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulantC Zoghlami-Rintelen, R Vormittag, T Sailer, et al.
European Journal of Haematology|December 12, 2001
Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutationC Rintelen, I Pabinger, P Bettelheim, et al.
Thrombosis Research|February 9, 1999
C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control studyW Lalouschek, S Aull, W Serles, et al.
The Journal of Pediatrics|February 5, 1999
Clinical significance of lupus anticoagulants in childrenC Male, K Lechner, S Eichinger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 18, 2009
Determinants of factor VIII plasma levels in carriers of haemophilia A and in control womenC Ay, K Thom, F Abu-Hamdeh, et al.
Pageof 22

Showing results (111-120 of 211) with videos related to

Sort By:
Pageof 22
Journal of Thrombosis and Haemostasis : JTH|November 11, 2014
Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS)I Pabinger, C Ay, D Dunkler, et al.
Human Mutation|January 1, 1994
(ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutationsR J Olds, D A Lane, V Chowdhury, et al.
British Journal of Haematology|February 13, 2001
Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)M Jansen, S Schmaldienst, S Banyai, et al.
Thrombosis Research|October 23, 1997
Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathwayK Ruzicka, S Kapiotis, P Quehenberger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 4, 2017
Haemophilia patients' unmet needs and their expectations of the new extended half-life factor concentratesS von Mackensen, W Kalnins, J Krucker, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulantC Zoghlami-Rintelen, R Vormittag, T Sailer, et al.
European Journal of Haematology|December 12, 2001
Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutationC Rintelen, I Pabinger, P Bettelheim, et al.
Thrombosis Research|February 9, 1999
C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control studyW Lalouschek, S Aull, W Serles, et al.
The Journal of Pediatrics|February 5, 1999
Clinical significance of lupus anticoagulants in childrenC Male, K Lechner, S Eichinger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 18, 2009
Determinants of factor VIII plasma levels in carriers of haemophilia A and in control womenC Ay, K Thom, F Abu-Hamdeh, et al.
Pageof 22